Stable liposomal formulations for ocular drug delivery
AssigneesNanyang Technological University, Singapore Health Services Pte Ltd
InventorsSubramanian Venkatraman, Jayaganesh V. Natarajan, Tina Howden, Freddy Boey
Life of this patent
Estimating the term…
Abstract
A stable liposomal formulation for ocular delivery. The formulation contains a liposome that includes at least one lipid bilayer containing a phosphatidylcholine, and a prostaglandin F2α encapsulated in the liposome. Also provided is a method for treating an ocular disorder with the formulation.
Claims6
A stable liposomal formulation for ocular delivery, the formulation comprising a liposome formed of palmitoyl oleoyl phosphatidyl choline (POPC), and latanoprost encapsulated in the liposome, wherein the liposome has a diameter of 100 nm to 300 nm, POPC is the sole lipid in the liposome, and the formulation is stable at 4° C. for up to 6 months.
Dependencies are inferred from the claim text.